PDCD1 and neoplasm: Nevertheless, there are some arguments for adapting the immunotherapy checkpoint to BC, such as results that show that PD-1 expression in tumor stroma in BC has been shown to be associated with an aggressive phenotype in terms of prognosis and is more common in TNBC [119].